Zoledronic acid Withdrawn Phase 2 Trials for Osteonecrosis Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00477217Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee